Related Experiment Video
Updated: Jun 20, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
What is "high risk?" a systematic review of atopy risk and implications for primary prevention
Sarah L Chamlin1, Kellee Kaulback, Anthony J Mancini
1Division of Pediatric Dermatology, Children's Memorial Hospital, Chicago, Illinois 60614, USA. schamlin@childrensmemorial.org
Insights
Identifying high-risk children for atopic diseases is crucial for prevention. Current methods are highly variable, highlighting the need for a standardized, validated screening tool to improve early detection and intervention strategies.
Area of Science:
- Pediatrics
- Allergy and Immunology
- Public Health
Background:
- Atopic diseases, such as asthma and eczema, are increasingly prevalent worldwide.
- Primary prevention strategies focus on identifying and intervening in high-risk children.
- Existing methods for identifying high-risk children in atopy prevention studies lack standardization.
Purpose of the Study:
- To evaluate the diverse methodologies employed to identify high-risk children within atopy prevention research.
- To assess the commonalities and variations in risk identification techniques used in published studies.
Main Methods:
- A comprehensive literature search was conducted for studies published between 1986 and 2006.
- Abstracts were screened, followed by a detailed review of selected articles.
- Fifty-seven studies met the inclusion criteria for analysis of risk identification methods.
Main Results:
- Thirty distinct methods were identified for defining high risk in children.
- Family history of atopy was the most frequently used predictor.
- Only a minority of studies utilized validated questionnaires for family history assessment; others relied solely on reported history.
Conclusions:
- The current approaches to identifying children at high risk for atopic diseases are inconsistent.
- There is a significant need for the development and implementation of a practical, validated screening tool for early identification.
Abstract:
Atopic diseases are common and becoming more prevalent. Efforts have focused on primary disease prevention by identifying high-risk children and applying preventative strategies. Our aim was to evaluate methods used to identify high-risk children in atopy prevention studies. A literature search for relevant articles published between 1986 and 2006 was conducted, and all abstracts were reviewed. The search yielded 1,535 publications, 133 were reviewed in detail, and 57 met inclusion criteria. High risk was defined by 30 different methods. First-degree relatives with an atopic disorder were included in all methods, but only three publications used referenced questionnaires to determine this. Less frequently included were cord blood immunoglobulin E measurements and skin prick or radioallergosorbent testing, and 16 methods relied on history alone. Family history was the most common method used to predict high risk of atopic disease in a child, but a minority of studies used a tested questionnaire to determine the presence of atopy in family members. The methods used to identify high-risk children are variable, and the development and widespread use of a validated, practical screening tool is needed.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction
Asthma-I: Introduction
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
